Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Haemostasis.

R L Speirs1

  • 1Hunterian Institute, Royal College of Surgeons, London.

Dental Update
|May 1, 1991
PubMed
Summary

Drugs that inhibit fibrin breakdown promote blood clotting (haemostasis). These are used to prevent bleeding during dental procedures and in patients with bleeding disorders, with new genetically engineered clotting factors offering future treatment options.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hyperventilation in the dental chair.

Dental update·1995
Same author

Stress and the immune system.

Dental update·1992
Same author

Food and oral health: 2. Periodontium and oral mucosa.

Dental update·1992
Same author

Food and oral health: 1. Dental caries.

Dental update·1992
Same author

Tongue skills and clearance of toffee in two age-groups and in children with problems of speech articulation.

ASDC journal of dentistry for children·1990
Same author

Phosphoprotein extraction from the dentine/cementum complex of human tooth roots.

Archives of oral biology·1990

Area of Science:

  • Biochemistry
  • Hematology
  • Pharmacology

Background:

  • Normal hemostasis relies on a delicate balance between coagulation and fibrinolysis.
  • Imbalances in this hemostatic process can lead to bleeding disorders.

Purpose of the Study:

  • To explore the role of drugs that inhibit fibrinolysis in promoting hemostasis.
  • To discuss the clinical applications of antifibrinolytic agents.
  • To highlight the potential of novel therapies for bleeding disorders.

Main Methods:

  • Review of existing literature on hemostasis and antifibrinolytic drugs.
  • Discussion of the mechanism of action of drugs inhibiting fibrin breakdown.
  • Exploration of the therapeutic use of these agents.

Main Results:

  • Drugs inhibiting fibrin breakdown effectively promote hemostasis.
  • These agents are clinically utilized in dental extractions and for preventing spontaneous bleeding.
  • Genetically engineered blood clotting factors represent a promising advancement in managing bleeding disorders.

Conclusions:

  • Inhibiting fibrinolysis is a viable strategy to enhance hemostasis.
  • Antifibrinolytic drugs offer significant benefits in specific clinical scenarios.
  • Future therapeutic approaches for bleeding disorders are being advanced by biotechnological innovations.

Related Experiment Videos